BioCentury | Mar 9, 2009
Strategy

Cephalon latches on again

Cephalon Inc. 's proposal to purchase Arana Therapeutics Inc. would provide a biologics platform as well as another clinical-stage product to its growing immunology pipeline. As for Arana, the offer - which is a 69% premium...
BioCentury | Mar 2, 2009
Company News

Arana, Cephalon deal

...includes Cephalon's purchase earlier in the same week of a 19.9% stake in Arana from Start-up Australia Ventures Pty. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Mar 9, 2009
Strategy

Cephalon latches on again

Cephalon Inc. 's proposal to purchase Arana Therapeutics Inc. would provide a biologics platform as well as another clinical-stage product to its growing immunology pipeline. As for Arana, the offer - which is a 69% premium...
BioCentury | Mar 2, 2009
Company News

Arana, Cephalon deal

...includes Cephalon's purchase earlier in the same week of a 19.9% stake in Arana from Start-up Australia Ventures Pty. Ltd....
Items per page:
1 - 2 of 2